Logo image of ECX

ECARX HOLDINGS INC-CL A (ECX) Stock Fundamental Analysis

NASDAQ:ECX - Nasdaq - KYG292011031 - Common Stock - Currency: USD

2.16  -0.04 (-1.82%)

After market: 2.18 +0.02 (+0.93%)

Fundamental Rating

2

Overall ECX gets a fundamental rating of 2 out of 10. We evaluated ECX against 81 industry peers in the Automobile Components industry. ECX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ECX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ECX had negative earnings in the past year.
ECX had negative earnings in each of the past 5 years.
ECX had a negative operating cash flow in each of the past 5 years.
ECX Yearly Net Income VS EBIT VS OCF VS FCFECX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -500M -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -19.64%, ECX is doing worse than 87.65% of the companies in the same industry.
Industry RankSector Rank
ROA -19.64%
ROE N/A
ROIC N/A
ROA(3y)-28.87%
ROA(5y)-28.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ECX Yearly ROA, ROE, ROICECX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500

1.3 Margins

ECX's Gross Margin of 20.39% is on the low side compared to the rest of the industry. ECX is outperformed by 70.37% of its industry peers.
ECX's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ECX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.97%
GM growth 5YN/A
ECX Yearly Profit, Operating, Gross MarginsECX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

ECX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ECX has more shares outstanding than it did 1 year ago.
ECX has a worse debt/assets ratio than last year.
ECX Yearly Shares OutstandingECX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M
ECX Yearly Total Debt VS Total AssetsECX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

ECX has an Altman-Z score of -1.86. This is a bad value and indicates that ECX is not financially healthy and even has some risk of bankruptcy.
ECX has a Altman-Z score of -1.86. This is amonst the worse of the industry: ECX underperforms 92.59% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.86
ROIC/WACCN/A
WACC7.6%
ECX Yearly LT Debt VS Equity VS FCFECX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M -500M -1B -1.5B

2.3 Liquidity

ECX has a Current Ratio of 0.60. This is a bad value and indicates that ECX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.60, ECX is not doing good in the industry: 96.30% of the companies in the same industry are doing better.
ECX has a Quick Ratio of 0.60. This is a bad value and indicates that ECX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.55, ECX is not doing good in the industry: 93.83% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.55
ECX Yearly Current Assets VS Current LiabilitesECX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ECX have decreased strongly by -119.55% in the last year.
Looking at the last year, ECX shows a very strong growth in Revenue. The Revenue has grown by 20.81%.
The Revenue has been growing by 26.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-119.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.9%
Revenue 1Y (TTM)20.81%
Revenue growth 3Y26.01%
Revenue growth 5YN/A
Sales Q2Q%851.28%

3.2 Future

The Earnings Per Share is expected to grow by 37.09% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.95% on average over the next years. This is quite good.
EPS Next Y63.97%
EPS Next 2Y47.33%
EPS Next 3Y37.09%
EPS Next 5YN/A
Revenue Next Year23.48%
Revenue Next 2Y26.86%
Revenue Next 3Y27.15%
Revenue Next 5Y18.95%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ECX Yearly Revenue VS EstimatesECX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ECX Yearly EPS VS EstimatesECX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 1 -1 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ECX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 31.88, ECX can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ECX is valued a bit more expensive than 77.78% of the companies in the same industry.
ECX is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 31.88
ECX Price Earnings VS Forward Price EarningsECX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECX Per share dataECX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

ECX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ECX's earnings are expected to grow with 37.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.33%
EPS Next 3Y37.09%

More info and screens

0

5. Dividend

5.1 Amount

ECX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECARX HOLDINGS INC-CL A

NASDAQ:ECX (7/3/2025, 7:19:09 PM)

After market: 2.18 +0.02 (+0.93%)

2.16

-0.04 (-1.82%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)N/A N/A
Inst Owners9.99%
Inst Owner Change219.09%
Ins Owners3.14%
Ins Owner Change0%
Market Cap800.78M
Analysts82.22
Price Target3.83 (77.31%)
Short Float %3.3%
Short Ratio1.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.07%
Min EPS beat(2)-55.62%
Max EPS beat(2)83.75%
EPS beat(4)1
Avg EPS beat(4)-49.41%
Min EPS beat(4)-176.9%
Max EPS beat(4)83.75%
EPS beat(8)3
Avg EPS beat(8)-27.67%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.24%
Min Revenue beat(2)8.27%
Max Revenue beat(2)10.2%
Revenue beat(4)4
Avg Revenue beat(4)7.9%
Min Revenue beat(4)1.51%
Max Revenue beat(4)11.59%
Revenue beat(8)5
Avg Revenue beat(8)-5.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.19%
EPS NQ rev (1m)36.24%
EPS NQ rev (3m)44.66%
EPS NY rev (1m)-37.86%
EPS NY rev (3m)-24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 31.88
P/S 0.98
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)0.07
Fwd EY3.14%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.2
BVpS-0.63
TBVpS-0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.39%
FCFM N/A
ROA(3y)-28.87%
ROA(5y)-28.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.97%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.55
Altman-Z -1.86
F-ScoreN/A
WACC7.6%
ROIC/WACCN/A
Cap/Depr(3y)112.86%
Cap/Depr(5y)115.42%
Cap/Sales(3y)2.33%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.9%
EPS Next Y63.97%
EPS Next 2Y47.33%
EPS Next 3Y37.09%
EPS Next 5YN/A
Revenue 1Y (TTM)20.81%
Revenue growth 3Y26.01%
Revenue growth 5YN/A
Sales Q2Q%851.28%
Revenue Next Year23.48%
Revenue Next 2Y26.86%
Revenue Next 3Y27.15%
Revenue Next 5Y18.95%
EBIT growth 1Y16.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.16%
EBIT Next 3Y41.35%
EBIT Next 5Y25.84%
FCF growth 1Y57.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.13%
OCF growth 3YN/A
OCF growth 5YN/A